Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
MGTX
MGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MGTX News
Strategic Shift in Biotech Dealmaking
Feb 17 2026
Globenewswire
Strategic Shift in Biopharma Dealmaking
Feb 17 2026
Newsfilter
Eli Lilly Enhances Genetic Eye Disease Pipeline Through Collaboration with MeiraGTx on Gene Therapy
Nov 10 2025
Benzinga
Eli Lilly Partners with MeiraGTx to Create Gene Therapies for Ocular Disorders
Nov 10 2025
SeekingAlpha
Raymond James Begins Coverage of MeiraGTx Holdings with Strong Buy Rating and Sets Price Target at $29
Oct 21 2025
Benzinga
Insider Sale: CFO & COO of $MGTX Sells 24,000 Shares
Jul 23 2025
NASDAQ.COM
Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday
May 14 2025
Benzinga
Chardan Capital Maintains Buy on MeiraGTx Hldgs, Lowers Price Target to $35
May 14 2025
Benzinga
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
May 13 2025
Newsfilter
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease
May 09 2025
Newsfilter
MeiraGTx price target raised to $13 from $11 at RBC Capital
Mar 17 2025
Business Insider
RBC Capital Keeps Their Buy Rating on Meiragtx Holdings (MGTX)
Mar 17 2025
Business Insider
Meiragtx Holdings (MGTX) Gets a Buy from Evercore ISI
Mar 17 2025
Business Insider
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales
Mar 13 2025
Benzinga
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday
Mar 13 2025
Benzinga
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars
Mar 13 2025
Benzinga
Show More News
